Edition:
India

Sinovac Biotech Ltd (SVA.OQ)

SVA.OQ on NASDAQ Stock Exchange Global Select Market

7.65USD
1:30am IST
Change (% chg)

$-0.09 (-1.16%)
Prev Close
$7.74
Open
$7.80
Day's High
$7.80
Day's Low
$7.65
Volume
924
Avg. Vol
12,854
52-wk High
$8.75
52-wk Low
$5.52

Latest Key Developments (Source: Significant Developments)

Sinovac Biotech Forced To Destroy Bacterial Seeds Intended For Production Of Vaccine
Monday, 30 Apr 2018 

April 30 (Reuters) - Sinovac Biotech Ltd ::SINOVAC BIOTECH - FORCED TO DESTROY BACTERIAL SEEDS INTENDED FOR USE IN PRODUCTION OF 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE.SINOVAC - FORCED TO SUSPEND PREPARATIONS FOR AND POSTPONE CHINA FDA INSPECTION OF MANUFACTURING SITE NEEDED FOR 23-VALENT PPV PRODUCTION APPROVAL.SINOVAC - DESTROYING BACTERIAL SEEDS, SUSPENDING PREPARATIONS FOR CFDA SITE INSPECTION TO DELAY COMMERCIALIZATION OF 23-VALENT PPV.  Full Article

Sinovac Announces Preliminary Results Of Phase Iii Trial On Sipv
Thursday, 19 Apr 2018 

April 19 (Reuters) - Sinovac Biotech Ltd ::SINOVAC ANNOUNCES PRELIMINARY RESULTS OF PHASE III TRIAL ON SIPV.SINOVAC BIOTECH - PRELIM RESULTS OF TRIAL AFTER UNBLINDING SHOW SEROCONVERSION RATE OF POLIOVIRUS TYPE II IS SUPERIOR TO CONTROL VACCINE.  Full Article

Sinovac Biotech Issues Statement In Response To Statements By Shandong Sinobioway Biomedicine Co Ltd
Thursday, 19 Apr 2018 

April 18 (Reuters) - Shandong Sinobioway Biomedicine Co Ltd <002581.SZ>::SINOVAC BIOTECH LTD - ISSUES STATEMENT IN RESPONSE TO STATEMENTS BY SHANDONG SINOBIOWAY BIOMEDICINE CO LTD.SINOVAC BIOTECH LTD - SINOVAC BEIJING HAS NOT REFUSED TO PROVIDE FINANCIAL STATEMENTS REQUESTED BY SINOBIOWAY BIOMEDICINE CO LTD.SINOVAC BIOTECH LTD SAYS HAVE BEEN IN REGULAR COMMUNICATIONS WITH SINOBIOWAY REGARDING PLANNED TIMING OF COMPLETION OF ANNUAL AUDIT.  Full Article

Sinovac Biotech Receives Positive Decision On Hepatitis A Vaccine From WHO
Friday, 22 Dec 2017 

Dec 22 (Reuters) - Sinovac Biotech Ltd ::SINOVAC BIOTECH RECEIVES POSITIVE DECISION ON ITS HEPATITIS A VACCINE FROM WORLD HEALTH ORGANIZATION.SINOVAC BIOTECH SAYS ‍RECEIVED POSITIVE DECISION FROM WHO ON ACCEPTABILITY OF HEALIVE, HEPATITIS A VACCINE , FOR PURCHASE BY UN AGENCIES​.  Full Article

Sinovac Biotech Announces Update On Nasdaq Matters
Thursday, 30 Nov 2017 

Nov 30 (Reuters) - Sinovac Biotech Ltd ::SINOVAC BIOTECH ANNOUNCES UPDATE ON NASDAQ MATTERS.SINOVAC BIOTECH- ‍NASDAQ HEARINGS PANEL GRANTED REQUEST TO EXTEND STAY OF SUSPENSION IN TRADING OF CO'S COMMON SHARES PENDING HEARING ON JAN 11, 2018​.  Full Article

Sinovac reports Q4 earnings per share $0.08
Thursday, 23 Nov 2017 

Nov 22 (Reuters) - Sinovac Biotech Ltd :Sinovac files 2016 annual report on form 20-F and reports unaudited fourth quarter 2016 financial results.Q4 earnings per share $0.08.Q4 sales rose 36.7 percent to $31.4 million.  Full Article

Sinovac posts Q2 loss of $0.17/share
Tuesday, 23 Aug 2016 

Sinovac Biotech Ltd: Sinovac reports unaudited second quarter 2016 financial results . Q2 loss per share $0.17 . Q2 non-GAAP loss per share $0.15 from continuing operations . Q2 sales $1.4 million versus $18.5 million . Will seek new commercial bank loans to finance commercialization of pipeline products . "Expect that sales in our fiscal second half of year will be much stronger than first half" .Expects that its current cash position will be able to support its operations for next 12 months.  Full Article

BRIEF-Sinovac Amends Shareholder Rights Plan

* SINOVAC BIOTECH LTD - ‍AMENDMENT EXTENDS EXPIRATION OF SHAREHOLDER RIGHTS PLAN FROM MARCH 27 TO MARCH 27, 2019​ Source text for Eikon: Further company coverage: